Legal Representation
Attorney
aoi nawashiro
USPTO Deadlines
Next Deadline
2118 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20251007)
Due Date
October 07, 2031
Grace Period Ends
April 07, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 7, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Oct 7, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 3, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 19, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 19, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 13, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 14, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 18, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 18, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 18, 2025 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Jan 31, 2025 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jan 31, 2025 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jan 31, 2025 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jan 10, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 10, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 10, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 21, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 21, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 21, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 21, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 15, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 8, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Enzymes for industrial purposes; Enzymes for scientific purposes; Enzyme preparations for industrial purposes; Enzyme preparations for scientific purposes; Enzymes for genome editing for scientific and research purposes; Enzymes preparations for genome editing for scientific and research purposes; Diagnostic preparations, other than for medical or veterinary purposes; Reagents for scientific purposes; Reagents for research purposes; Reagents for genome editing for scientific and research purposes; Crispr inhibitors being biochemical, chemical, and biological preparations for scientific and research purposes; Crispr controls being biochemical, chemical, and biological preparations for scientific and research purposes; Crispr reagents for genome editing for scientific and research purposes; Chemical substances for use in the biotechnological industry; Chemical reagents for use in biotechnology, other than for medical or veterinary use; Chemical preparations for use in DNA analysis, other than medical use; Enzyme preparations for use in DNA analysis, other than medical use; Enzymes for use in DNA analysis, other than medical use; Chemical preparations for use in RNA analysis, other than medical use; Enzyme preparations for use in RNA analysis, other than medical use; Enzymes for use in RNA analysis, other than medical use; Enzymes for editing genomes for medical or veterinary research purposes
Class 005
Enzymes for medical purposes; Enzymes for veterinary purposes; Enzyme preparations for medical purposes; Enzyme preparations for veterinary purposes; Enzyme preparations for editing genomes for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Reagents for use in medical genetic testing; Reagents for use in veterinary genetic testing; Reagents for genome editing for medical or veterinary purposes; Crispr inhibitors being biochemical, chemical, and biological preparations for medical or veterinary purposes; Crispr controls being biochemical, chemical, and biological preparations for medical or veterinary purposes; Crispr reagents for genome editing for medical or veterinary purposes; Chemical preparations for use in DNA analysis for medical or veterinary purposes; Enzyme preparations for use in DNA analysis for medical or veterinary purposes; Enzymes for use in DNA analysis for medical or veterinary purposes; Chemical preparations for use in RNA analysis for medical or veterinary purposes; Enzyme preparations for use in RNA analysis for medical or veterinary purposes; Enzymes for use in RNA analysis for medical or veterinary purposes
Class 042
Research in the field of gene therapy; Advisory services relating to gene therapy research; Research in the field of gene editing technology; Advisory services in the field of gene editing technology; Genome editing for scientific purposes; Genome editing for scientific research purposes; Genome editing for industrial purposes; Genome editing for use in biotechnology, other than for medical or veterinary use
Class 044
Genome editing for medical purposes; Genome editing for veterinary purposes
Additional Information
Translation
The wording MUNTANA has no meaning in a foreign language.
Classification
International Classes
001
005
042
044